Contents

Search


piribedil (Trivastal)

Tradename: Trivastal. Indications: 1) symptomatic treatment of Parkinson's disease 2) may be useful for treating apathy after bilateral subthalamic deep brain stimulation [1] Dosage: 50 mg QD Mechanism of action: -> dopamine D2 receptor agonist, dopamine D3 receptor agonist

Interactions

drug adverse effects (more general classes)

General

dopaminergic receptor agonist pharmacologic agents for treatment of Parkinson's disease

Properties

AGONIST-FOR: adrenergic receptor

Database Correlations

PUBCHEM correlations

References

  1. Thobois S et al. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil. Brain 2013 May; 136:1568 PMID: 23543483